Autolus Therapeutics to Report Third Quarter 2021 Financial Results and Host Conference Call on November 3

Rhea-AI Summary

Autolus Therapeutics plc (Nasdaq: AUTL) announced its plan to release third quarter 2021 financial results on November 3, 2021, before U.S. markets open. The company’s management will host a conference call at 8:30 am ET to discuss the financial results and provide a business update. Interested parties can access the webcast through the company’s events section on its website. The call can also be dialed in using provided numbers for U.S. and international callers with a reference conference ID of 6984737.

Positive

• Upcoming financial results announcement expected to provide insights into company performance.
• Conference call scheduled for November 3, allowing investors to gain updates directly from management.

Negative

• None.

LONDON, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its third quarter 2021 financial results and operational highlights before open of U.S. markets on Wednesday, November 3, 2021.

Management will host a conference call and webcast at 8:30 am ET/1:30 pm GMT to discuss the company’s financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to the events section of Autolus’ website.

The call may also be accessed by dialing (866) 679-5407 for U.S. and Canada callers or (409) 217-8320 for international callers. Please reference conference ID 6984737. After the conference call, a replay will be available for one week. To access the replay, please dial (855) 859-2056 for U.S. and Canada callers or (404) 537-3406 for international callers. Please reference conference ID 6984737.

Contact:

Lucinda Crabtree, PhD
Vice President, Business Strategy and Planning
+44 (0) 7587 372 619 
l.crabtree@autolus.com

Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com

Susan A. Noonan
S.A. Noonan Communications
+1-212-966-3650
susan@sanoonan.com

FAQ

When will Autolus Therapeutics release its Q3 2021 financial results?

Autolus Therapeutics will release its Q3 2021 financial results on November 3, 2021, before U.S. markets open.

What time is the Autolus Therapeutics conference call scheduled?

The conference call is scheduled for 8:30 am ET on November 3, 2021.

How can I access the Autolus Therapeutics earnings call?

You can access the Autolus Therapeutics earnings call through their events section on the company's website or by dialing the provided conference call numbers.

What is the conference ID for the Autolus Therapeutics call?

The conference ID for the Autolus Therapeutics call is 6984737.